On September 9, the DC Circuit Court of Appeals issued a Per Curiam Order declining to stay Attorney General Blanche’s historic rescheduling of medical cannabis. In April 2026, at President Trump’s direction, Attorney General Blanche moved medical cannabis approved by the U.S. FDA and medical cannabis approved through a state-regulated medical cannabis program to a Schedule III substance – it reclassified medical cannabis as medicine and distinguished it from illegal substances such as heroin and LSD. This was a historic move. Shortly after, multiple prohibitionist groups challenged the move to Schedule III and sought to freeze its implementation while the challenge is pending. In a win for the medical cannabis industry, the Court denied the request to freeze it.

Read full order here.